Metformin



Combined with:

Asa
Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 45.9%
Type 2 Diabetes Mellitus 21.4%
Diabetes Mellitus 15.3%
Hypertension 5.7%
Diabetes Mellitus Non-insulin-dependent 2.2%
Drug Use For Unknown Indication 1.7%
Polycystic Ovaries 0.9%
Depression 0.8%
Atrial Fibrillation 0.7%
Suicide Attempt 0.7%
Gestational Diabetes 0.6%
Hypercholesterolaemia 0.6%
Type 1 Diabetes Mellitus 0.6%
Rheumatoid Arthritis 0.5%
Dyslipidaemia 0.5%
Hyperglycaemia 0.5%
Hiv Infection 0.4%
Osteoarthritis 0.4%
Intentional Overdose 0.4%
Asthma 0.3%
Renal Failure Acute 21.1%
Vomiting 15.5%
Lactic Acidosis 8.2%
Toxicity To Various Agents 7.0%
Renal Impairment 6.1%
Completed Suicide 5.7%
Suicide Attempt 4.0%
Poisoning 3.8%
Renal Failure 3.7%
Weight Decreased 3.2%
Sepsis 2.7%
Shock 2.7%
Somnolence 2.6%
Death 2.2%
Hypoglycaemia 2.1%
Metabolic Acidosis 2.1%
Hypoglycaemic Coma 2.0%
Pancreatitis Acute 2.0%
Overdose 1.8%
Nausea 1.7%
Secondary
Product Used For Unknown Indication 33.2%
Type 2 Diabetes Mellitus 21.0%
Diabetes Mellitus 11.5%
Hypertension 10.9%
Drug Use For Unknown Indication 7.1%
Diabetes Mellitus Non-insulin-dependent 2.4%
Depression 2.0%
Suicide Attempt 1.3%
Hiv Infection 1.0%
Prophylaxis 1.0%
Blood Cholesterol Increased 1.0%
Rheumatoid Arthritis 1.0%
Hypercholesterolaemia 0.9%
Foetal Exposure During Pregnancy 0.9%
Pain 0.9%
Anxiety 0.8%
Dyslipidaemia 0.8%
Ill-defined Disorder 0.8%
Asthma 0.7%
Completed Suicide 0.7%
Renal Failure Acute 15.4%
Completed Suicide 9.6%
Vomiting 9.3%
Toxicity To Various Agents 7.2%
Weight Decreased 6.3%
Hypoglycaemia 6.1%
Weight Increased 5.3%
Overdose 4.5%
Renal Failure 4.3%
Drug Ineffective 4.2%
Blood Glucose Increased 3.6%
Nausea 3.6%
Death 3.5%
White Blood Cell Count Increased 3.2%
Pancreatitis Acute 2.8%
Somnolence 2.8%
Drug Hypersensitivity 2.7%
Colitis Microscopic 1.9%
Myocardial Infarction 1.9%
Haemorrhage 1.8%
Concomitant
Product Used For Unknown Indication 30.6%
Diabetes Mellitus 15.9%
Hypertension 10.4%
Type 2 Diabetes Mellitus 10.3%
Drug Use For Unknown Indication 7.7%
Blood Cholesterol Increased 3.2%
Rheumatoid Arthritis 2.8%
Depression 2.6%
Pain 2.6%
Diabetes Mellitus Non-insulin-dependent 2.4%
Gastrooesophageal Reflux Disease 1.4%
Atrial Fibrillation 1.3%
Asthma 1.3%
Prophylaxis 1.3%
Cardiac Disorder 1.1%
Anxiety 1.1%
Hepatitis C 1.0%
Psoriasis 1.0%
Hypothyroidism 1.0%
Blood Pressure 0.9%
Weight Decreased 17.4%
Vomiting 10.2%
Weight Increased 6.5%
Drug Ineffective 6.3%
Nausea 6.1%
Myocardial Infarction 5.9%
Blood Glucose Increased 5.5%
Pain 4.8%
Pancreatitis 4.3%
Flushing 4.0%
Pruritus 3.7%
Renal Failure Acute 3.3%
Pain In Extremity 3.3%
Urinary Tract Infection 2.9%
Rash 2.9%
Vision Blurred 2.8%
Death 2.7%
Tremor 2.6%
Injection Site Pain 2.4%
Paraesthesia 2.3%
Interacting
Product Used For Unknown Indication 40.4%
Type 2 Diabetes Mellitus 17.6%
Hypertension 9.0%
Diabetes Mellitus 6.4%
Cardiac Disorder 4.3%
Ascites 2.1%
Pain 2.1%
Back Pain 1.6%
Blood Glucose Fluctuation 1.6%
Depression 1.6%
Ischaemic Heart Disease Prophylaxis 1.6%
Nervous System Disorder 1.6%
Nervousness 1.6%
Prophylaxis Against Gastrointestinal Ulcer 1.6%
Renal Impairment 1.6%
Acarodermatitis 1.1%
Blood Cholesterol Increased 1.1%
Cardiovascular Event Prophylaxis 1.1%
Chest Pain 1.1%
Chronic Hepatitis 1.1%
Renal Failure Acute 24.5%
Drug Interaction 16.3%
Hypoglycaemia 6.1%
Renal Tubular Acidosis 6.1%
Hypoglycaemic Coma 4.1%
Illusion 4.1%
Overdose 4.1%
Renal Impairment 4.1%
Tremor 4.1%
Vomiting 4.1%
Weight Increased 4.1%
Blood Pressure Increased 2.0%
Hyperglycaemia 2.0%
Hyperhidrosis 2.0%
Hypokalaemia 2.0%
Lactic Acidosis 2.0%
Mania 2.0%
Nausea 2.0%
Off Label Use 2.0%
Pancreatitis Acute 2.0%